[Status and perspectives of registry-based studies in German ophthalmology].

Stand und Perspektiven registerbasierter Studien in der deutschen Augenheilkunde.
Epidemiology Multicenter study Registry Reimbursement Study design

Journal

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft
ISSN: 1433-0423
Titre abrégé: Ophthalmologe
Pays: Germany
ID NLM: 9206148

Informations de publication

Date de publication:
Jan 2020
Historique:
pubmed: 10 7 2019
medline: 24 1 2020
entrez: 10 7 2019
Statut: ppublish

Résumé

Registry studies provide insights into real-life diagnostic and treatment data outside of clinical trials. Registry studies are interesting for quality management and explorative analyses can lead to the identification of possible risk or prognostically relevant factors and generate hypotheses. There are currently relatively few active registry studies in German ophthalmology. The aim of this survey was to collate the different infrastructure and in particular the potential hurdles in the establishment and performance of registry studies in German ophthalmology departments. An online questionnaire collected data on participation in registry studies in German ophthalmology departments between September and December 2018. The survey was addressed to all hospital management and medical staff involved in registry studies in German ophthalmology. Out of 45 participants 18 were head of the department, the remaining 27 were consultants (15), medical specialists (2) and residents (10). According to the department head an average of 2.5 (2.0-3.5) employees per clinic participate in 2.0 (1.7-3.0) registry studies. The amount of reimbursement recommended by the hospital management differed significantly from the amount suggested by the staff (0.0 (0; 75) € (0-100) vs. 100.0 (50.0; 150.0) €; p = 0.0012). The most frequent hurdles to conducting a registry study were bureaucracy and limited human resources. Half of the surveyed centers profited from a separate study center and good clinical practice (GCP) courses for employees involved in studies were mandatory. A quarter of these centers received support from an IT department and/or a statistician. Registry studies are an important instrument in ophthalmology research and their importance is increasing in Germany. An agreement on national standards would make the establishment of further registry studies easier.

Sections du résumé

BACKGROUND AND OBJECTIVE OBJECTIVE
Registry studies provide insights into real-life diagnostic and treatment data outside of clinical trials. Registry studies are interesting for quality management and explorative analyses can lead to the identification of possible risk or prognostically relevant factors and generate hypotheses. There are currently relatively few active registry studies in German ophthalmology. The aim of this survey was to collate the different infrastructure and in particular the potential hurdles in the establishment and performance of registry studies in German ophthalmology departments.
METHODS METHODS
An online questionnaire collected data on participation in registry studies in German ophthalmology departments between September and December 2018. The survey was addressed to all hospital management and medical staff involved in registry studies in German ophthalmology.
RESULTS RESULTS
Out of 45 participants 18 were head of the department, the remaining 27 were consultants (15), medical specialists (2) and residents (10). According to the department head an average of 2.5 (2.0-3.5) employees per clinic participate in 2.0 (1.7-3.0) registry studies. The amount of reimbursement recommended by the hospital management differed significantly from the amount suggested by the staff (0.0 (0; 75) € (0-100) vs. 100.0 (50.0; 150.0) €; p = 0.0012). The most frequent hurdles to conducting a registry study were bureaucracy and limited human resources. Half of the surveyed centers profited from a separate study center and good clinical practice (GCP) courses for employees involved in studies were mandatory. A quarter of these centers received support from an IT department and/or a statistician.
CONCLUSION CONCLUSIONS
Registry studies are an important instrument in ophthalmology research and their importance is increasing in Germany. An agreement on national standards would make the establishment of further registry studies easier.

Identifiants

pubmed: 31286190
doi: 10.1007/s00347-019-0931-1
pii: 10.1007/s00347-019-0931-1
doi:

Types de publication

Journal Article

Langues

ger

Sous-ensembles de citation

IM

Pagination

36-43

Références

Ophthalmology. 2019 May;126(5):655-662
pubmed: 30572076
Am J Ophthalmol. 2018 Apr;188:91-98
pubmed: 29410297
Ophthalmology. 2010 Aug;117(8):1469-70
pubmed: 20682375
Eur J Epidemiol. 2019 Mar;34(3):301-317
pubmed: 30830562
Ophthalmologe. 2019 Oct;116(10):957-966
pubmed: 30810837
Ophthalmologe. 2018 Oct;115(10):826-831
pubmed: 29766264
Gesundheitswesen. 2010 Nov;72(11):824-39
pubmed: 20872343
Eye (Lond). 2003 Jan;17(1):9-15
pubmed: 12579163
Unfallchirurg. 2016 Jun;119(6):493-500
pubmed: 27169850

Auteurs

M Roth (M)

Klinik für Augenheilkunde, Universitätsklinikum Düsseldorf, Moorenstr. 5, 40225, Düsseldorf, Deutschland. mathias.roth@med.uni-duesseldorf.de.

C Holtmann (C)

Klinik für Augenheilkunde, Universitätsklinikum Düsseldorf, Moorenstr. 5, 40225, Düsseldorf, Deutschland.

D Böhringer (D)

Klinik für Augenheilkunde, Universitätsklinikum Freiburg, Freiburg, Deutschland.

R P Finger (RP)

Klinik für Augenheilkunde, Universitätsklinikum Bonn, Bonn, Deutschland.

N Eter (N)

Klinik für Augenheilkunde, Universitätsklinikum Münster, Münster, Deutschland.

B Seitz (B)

Klinik für Augenheilkunde, Universitätsklinikum des Saarlandes UKS, Homburg/Saar, Deutschland.

G Geerling (G)

Klinik für Augenheilkunde, Universitätsklinikum Düsseldorf, Moorenstr. 5, 40225, Düsseldorf, Deutschland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH